Iron Deficiency Anemia: Complete ICD-11 Coding Guide
1. Introduction
Iron deficiency anemia represents the most common nutritional deficiency worldwide, affecting millions of people of all ages, especially women of reproductive age, children, and pregnant women. This condition occurs when the body does not have sufficient iron to produce adequate hemoglobin, the protein responsible for oxygen transport in red blood cells. The deficiency may develop gradually, beginning with depletion of iron stores, progressing to iron-deficient erythropoiesis, and finally culminating in manifest anemia.
The clinical importance of this condition transcends the immediate symptoms of fatigue and weakness. Iron deficiency anemia can significantly compromise quality of life, reduce productive capacity, affect cognitive development in children, and increase the risk of complications during pregnancy. In public health contexts, it represents a substantial challenge, particularly in regions with limited resources, where malnutrition and intestinal parasitic infections are prevalent.
Appropriate coding of this condition in the ICD-11 system is fundamental for multiple purposes: it enables precise epidemiological tracking, facilitates appropriate resource allocation, aids in planning public health interventions, and ensures correct reimbursement in health systems. Healthcare professionals must understand not only the clinical aspects of iron deficiency anemia, but also the specific criteria for its correct coding, differentiating it from other forms of anemia that require distinct codes.
2. Correct ICD-11 Code
Code: 3A00
Description: Iron deficiency anemia
Parent category: Nutritional or metabolic anemias
Official definition: Disease caused by chronic or acute bleeding, increased menstrual bleeding, inadequate intake, substances (in diet or medications) interfering with iron absorption, malabsorption syndromes, inflammation, infection, and blood donation. This disease is characterized by decreased levels of iron present in the body. This disease may manifest with fatigue, pallor, and dizziness. Confirmation is made by identifying decreased iron levels in a blood sample.
Code 3A00 belongs to the chapter of diseases of the blood and hematopoietic organs, specifically within the category of nutritional or metabolic anemias. This classification reflects the primarily nutritional nature of the condition, although it recognizes that multiple factors may contribute to its etiology. The hierarchical structure of ICD-11 allows greater diagnostic specificity when compared to the previous version, facilitating precise identification of different causes of anemia.
This code should be used when there is laboratory confirmation of iron deficiency as the primary cause of anemia, regardless of the underlying mechanism that led to the deficiency. Adequate documentation should include not only laboratory values, but also etiological investigation that identified the cause of iron deficiency.
3. When to Use This Code
Scenario 1: Woman with Chronic Menorrhagia
A 35-year-old patient presents with complaints of progressive fatigue over the past six months, associated with a history of heavy and prolonged menstruation. The complete blood count reveals hemoglobin of 9.5 g/dL, reduced mean corpuscular volume (MCV), and iron studies demonstrate low ferritin, decreased serum iron, and increased total iron-binding capacity. Code 3A00 is appropriate after exclusion of other causes of bleeding.
Scenario 2: Patient with Celiac Disease and Malabsorption
An adult with confirmed diagnosis of celiac disease non-adherent to a gluten-free diet develops microcytic hypochromic anemia. Laboratory investigation confirms iron deficiency with depleted stores. In this case, although there is an underlying gastrointestinal condition, code 3A00 is used for the anemia and may be supplemented with the celiac disease code as an associated condition.
Scenario 3: Child with Inadequate Diet
An 18-month-old child presents with pallor and irritability. Dietary history reveals excessive cow's milk consumption and low intake of iron-rich foods. The complete blood count shows microcytic anemia with significantly reduced serum ferritin. Code 3A00 is applicable, documenting nutritional iron deficiency.
Scenario 4: Regular Blood Donor
A regular volunteer blood donor who donates every three months develops symptoms of fatigue and dyspnea on exertion. Laboratory evaluation identifies iron deficiency anemia with depleted iron stores. Code 3A00 is correct, recognizing blood donation as the causal mechanism.
Scenario 5: Patient Post-Bariatric Surgery
A patient who underwent gastric bypass two years ago presents with progressive anemia. Investigation reveals iron deficiency secondary to malabsorption in the proximal small intestine. Laboratory parameters confirm iron deficiency anemia. Code 3A00 is appropriate and may be coded together with the bariatric procedure code as context.
Scenario 6: Occult Gastrointestinal Bleeding
A 60-year-old man with microcytic anemia is investigated, revealing positive fecal occult blood test. Colonoscopy identifies bleeding colonic polyps. Iron studies confirm deficiency. Code 3A00 is used for the anemia, with an additional code for the polyps as the underlying cause.
4. When NOT to Use This Code
Code 3A00 should not be used when anemia results from other specific nutritional deficiencies. If anemia is caused primarily by vitamin B12 deficiency, even if mild iron deficiency coexists, the appropriate code is 3A01 (Megaloblastic anemia due to vitamin B12 deficiency). The distinction is made through the morphological pattern of red blood cells and serum vitamin B12 levels.
Do not use this code for folate deficiency anemia (3A02), which also produces megaloblastic anemia with distinct morphological characteristics. Differentiation requires specific serum and erythrocyte folate dosage, in addition to blood smear evaluation showing macrocytes and hypersegmented neutrophils.
Avoid using 3A00 for anemias of chronic disease (anemia of inflammation), even when serum iron levels are low. In these situations, ferritin is usually normal or elevated due to iron sequestration by macrophages, and total iron binding capacity is reduced or normal, contrasting with the pattern of true iron deficiency.
Do not code as 3A00 hemolytic, aplastic, or sideroblastic anemias, which have specific codes in ICD-11. These conditions have completely different pathophysiological mechanisms and require distinct therapeutic approaches.
Thalassemias and other hemoglobinopathies that may present with microcytosis should also not be coded as 3A00, even when some iron deficiency coexists. In these cases, the primary code should reflect the underlying hemoglobinopathy.
5. Step-by-Step Coding Process
Step 1: Assess Diagnostic Criteria
The diagnosis of iron deficiency anemia requires laboratory confirmation through multiple parameters. First, the presence of anemia must be documented through a complete blood count, with hemoglobin values below the reference limits adjusted for age and sex. The mean corpuscular volume (MCV) is generally reduced, characterizing microcytosis, although in early stages it may be normal.
Specific iron studies are essential: reduced serum ferritin (generally below 30 ng/mL, although this value may be higher in inflammatory contexts), decreased serum iron, increased total iron-binding capacity (TIBC), and reduced transferrin saturation (typically below 20%). Ferritin is the most sensitive test for assessing iron stores, but may be falsely elevated in inflammatory states.
The peripheral blood smear may reveal additional characteristics such as hypochromia (pale red blood cells), anisocytosis (variation in size), and poikilocytosis (variation in shape). The presence of target cells or elliptocytes may suggest alternative conditions.
Step 2: Verify Specifiers
The severity of anemia must be documented based on hemoglobin levels: mild, moderate, or severe. This information, although it does not change the main code 3A00, is clinically relevant and should be included in the medical record to guide therapeutic decisions.
Identify and document the underlying cause of iron deficiency: bleeding (menstrual, gastrointestinal, urinary), malabsorption (celiac disease, bariatric surgery, atrophic gastritis), increased requirements (pregnancy, lactation, rapid growth), or inadequate intake. This information may require additional codes for associated conditions.
Assess the chronicity of the condition. Iron deficiency anemia typically develops over months, but may occur more rapidly in situations of significant acute bleeding. The duration of symptoms and laboratory progression should be documented.
Step 3: Differentiate from Other Codes
3A01 - Megaloblastic anemia due to vitamin B12 deficiency: Differentiated by the presence of macrocytosis (elevated MCV), hypersegmented neutrophils on smear, and low serum vitamin B12 levels. Clinically, there may be neurological manifestations such as paresthesias and cognitive changes, absent in iron deficiency anemia.
3A02 - Anemia due to folate deficiency: Also presents with macrocytosis and megaloblastosis in bone marrow. Differentiation requires serum and erythrocyte folate dosage. Frequently associated with alcoholism, malabsorption, or use of antimetabolite medications. Does not present the neurological changes of B12 deficiency.
3A03 - Other metabolic or nutritional anemias: This code is used for less common nutritional deficiencies that cause anemia, such as copper, protein, or vitamin E deficiency. Differentiation requires specific investigation when standard tests for iron, B12, and folate do not explain the anemia.
Step 4: Required Documentation
Complete documentation should include: hemoglobin, hematocrit, and red cell indices values (MCV, MCH, MCHC); results of iron studies (ferritin, serum iron, TIBC, transferrin saturation); description of peripheral blood smear; detailed clinical history including symptoms, duration, risk factors; etiological investigation performed (menstrual history, gastrointestinal evaluation, dietary history); and treatment response when applicable.
Record additional codes for causal or associated conditions, such as peptic ulcer, menorrhagia, celiac disease, or other gastrointestinal conditions. Document medications that may interfere with iron absorption, such as proton pump inhibitors or antacids.
6. Complete Practical Example
Clinical Case
A 42-year-old female patient, a teacher, presents to medical consultation with the chief complaint of progressive fatigue over the last eight months, initially mild but now interfering with her daily activities. She reports dyspnea with moderate exertion, such as climbing stairs, and difficulty concentrating at work. She also mentions hair loss and brittle nails over the last few months.
In her gynecological history, she reports regular menstrual cycles but with increased flow over the last two years, requiring changing sanitary pads every two hours on days of heavier flow, lasting seven days. She denies use of intrauterine device or hormonal contraceptive. She has no history of gastrointestinal bleeding, melena, or hematochezia. She denies significant gastrointestinal symptoms. Diet is varied, without specific restrictions.
On physical examination: evident cutaneous-mucosal pallor, heart rate of 92 bpm at rest, blood pressure 110/70 mmHg. Cardiovascular examination reveals a functional systolic murmur. Abdomen without abnormalities. Gynecological examination without apparent structural abnormalities.
Laboratory tests ordered reveal: Hemoglobin 8.2 g/dL (reference: 12-16 g/dL), Hematocrit 26%, MCV 68 fL (reference: 80-100 fL), MCH 21 pg (reference: 27-32 pg), RDW 18% (elevated), normal leukocytes and platelets. Iron studies: Ferritin 8 ng/mL (reference: 15-150 ng/mL), Serum iron 25 μg/dL (reference: 60-170 μg/dL), TIBC 450 μg/dL (reference: 250-400 μg/dL), Transferrin saturation 5.5% (reference: 20-50%).
Peripheral blood smear: marked microcytosis, hypochromia, anisocytosis, presence of pencil cells. Absence of macrocytes or hypersegmented neutrophils.
Pelvic ultrasound performed demonstrates an intramural uterine fibroid of 4 cm, without other significant abnormalities. Fecal occult blood test negative.
Step-by-Step Coding
Criteria analysis:
- Confirmed anemia: hemoglobin 8.2 g/dL (moderate)
- Microcytic hypochromic pattern: MCV 68 fL, MCH 21 pg
- Confirmed iron deficiency: low ferritin (8 ng/mL), low serum iron, elevated TIBC, markedly reduced transferrin saturation
- Identified cause: chronic menorrhagia secondary to uterine fibroid
- Exclusion of other causes: no evidence of gastrointestinal bleeding, no malabsorption symptoms, no megaloblastic pattern
Code selected: 3A00 - Iron deficiency anemia
Complete justification: Code 3A00 is appropriate because all diagnostic criteria are present: anemia documented by laboratory findings, characteristic morphological pattern (microcytosis and hypochromia), biochemical confirmation of iron deficiency through multiple parameters (ferritin, serum iron, TIBC, and transferrin saturation), and identification of the underlying cause (increased menstrual blood loss). The peripheral blood smear corroborates the diagnosis and excludes other etiologies such as megaloblastic anemia.
Complementary codes:
- Code for uterine fibroid (underlying cause of menorrhagia)
- Code for menorrhagia, if separate coding is necessary in the clinical context
Complete documentation allows for epidemiological tracking, justifies iron replacement therapy, and identifies the need for definitive fibroid treatment to prevent recurrence.
7. Related Codes and Differentiation
Within the Same Category
3A01: Megaloblastic anemia due to vitamin B12 deficiency
Use 3A01 when: the complete blood count shows macrocytosis (MCV > 100 fL), the blood smear reveals oval macrocytes and hypersegmented neutrophils, and serum vitamin B12 levels are reduced. Patients may present with neurological symptoms such as paresthesias, ataxia, or cognitive changes.
Main difference: Iron deficiency anemia (3A00) is microcytic with reduced MCV, while B12 deficiency (3A01) is macrocytic with elevated MCV. Iron studies are altered in 3A00 (low ferritin, high TIBC), but normal or with paradoxically elevated serum iron in 3A01. B12 deficiency is frequently associated with atrophic gastritis, pernicious anemia, or intestinal malabsorption.
3A02: Anemia due to folate deficiency
Use 3A02 when: there is significant macrocytosis, megaloblastosis on bone marrow examination, and reduced serum or erythrocyte folate levels. Commonly associated with chronic alcoholism, intestinal malabsorption, pregnancy with inadequate supplementation, or use of antifolate medications.
Main difference: Similar to B12 deficiency, folate deficiency (3A02) produces macrocytic anemia, contrasting with the microcytosis of iron deficiency anemia (3A00). However, unlike B12 deficiency, folate deficiency does not cause neurological manifestations. The clinical history frequently reveals specific risk factors such as alcoholism or an extremely poor diet lacking vegetables.
3A03: Other metabolic or nutritional anemias
Use 3A03 when: anemia clearly results from nutritional deficiency, but tests for iron, B12, and folate do not completely explain the clinical picture. Includes rare deficiencies such as copper, protein, vitamin E, or other vitamins essential for erythropoiesis.
Main difference: This code (3A03) is essentially one of exclusion, used when common nutritional causes have been ruled out. Iron deficiency anemia (3A00) has a characteristic and well-defined laboratory pattern, while 3A03 requires more extensive and specialized investigation to identify the specific deficiency.
Differential Diagnoses
Anemia of chronic disease: May present with mild microcytosis and low serum iron, but ferritin is normal or elevated (not low), and TIBC is reduced or normal (not elevated). Clinical context of chronic inflammation, infection, or malignancy.
Thalassemia minor: Presents with marked microcytosis disproportionate to the degree of anemia, but iron studies are normal. Hemoglobin electrophoresis reveals a characteristic pattern with elevation of HbA2 in beta-thalassemia.
Sideroblastic anemia: May have microcytosis, but serum iron and ferritin are elevated, not reduced. Diagnosis requires bone marrow aspirate showing ring sideroblasts.
8. Differences with ICD-10
In ICD-10, iron deficiency anemia was coded as D50, with subdivisions to specify the cause: D50.0 (anemia due to chronic blood loss), D50.1 (sideropenic dysphagia), D50.8 (other iron deficiency anemias), and D50.9 (iron deficiency anemia, unspecified).
The main change in ICD-11 is simplification to a single code 3A00, with the expectation that the underlying cause be coded separately when relevant. This approach reduces coding complexity and avoids confusion about which specific subcategory to use, a common problem in ICD-10.
The practical impact is significant: in ICD-11, the coder does not need to decide between multiple subcategories of iron deficiency anemia, simplifying the process. However, it becomes even more important to adequately code the causal conditions (such as menorrhagia, peptic ulcer, or malabsorption) as additional codes to maintain clinical specificity.
Health information systems need to adapt to this change, especially in epidemiological reports that previously stratified by ICD-10 subcategories. The transition requires adequate training of coders and adjustments in electronic health record systems.
9. Frequently Asked Questions
How is iron deficiency anemia diagnosed?
Diagnosis requires a combination of clinical history, physical examination, and laboratory confirmation. Complete blood count identifies anemia (reduced hemoglobin) and morphological characteristics (microcytosis, hypochromia). Iron studies are essential: low serum ferritin is the most sensitive indicator of iron store depletion, while low serum iron, elevated total iron-binding capacity, and reduced transferrin saturation confirm functional deficiency. Peripheral blood smear complements the evaluation by showing characteristic morphological changes. Investigation should include search for underlying cause through detailed menstrual history, gastrointestinal evaluation when indicated, and dietary history.
Is treatment available in public health systems?
Yes, treatment of iron deficiency anemia with oral iron supplementation is widely available in public health systems worldwide and is considered an essential medicine by the World Health Organization. Ferrous sulfate, ferrous gluconate, or ferrous fumarate formulations are low-cost and highly effective options. In specific situations where the oral route is ineffective or not tolerated, intravenous iron formulations may be necessary, although with higher cost and more restricted availability. Access to treatment generally does not represent a significant barrier, with identification and correction of the underlying cause often being more challenging.
How long does treatment last?
Typical treatment with oral iron supplementation extends for three to six months. Initial response is evidenced by increased reticulocyte count in five to ten days, followed by gradual hemoglobin elevation over four to eight weeks. However, even after hemoglobin normalization, supplementation should continue for an additional three to six months to completely replete body iron stores, evidenced by normalization of serum ferritin. Duration may be prolonged if the underlying cause is not corrected or if there is malabsorption. Periodic laboratory monitoring is recommended to assess response and adjust treatment duration as needed.
Can this code be used in medical certificates?
Yes, code 3A00 can and should be used in medical certificates when appropriate, especially in situations where anemia causes significant functional limitation that justifies work absence or activity restrictions. Intense fatigue, dyspnea on exertion, and impaired concentration capacity may justify temporary absence, particularly in work activities requiring significant physical effort or high cognitive demand. Documentation should include anemia severity and specific functional impact. Certificates for pregnant women with iron deficiency anemia may have additional considerations due to risks to pregnancy.
Can iron deficiency anemia recur after treatment?
Yes, recurrence is common if the underlying cause is not adequately treated. Women with persistent menorrhagia, patients with unresolved chronic gastrointestinal bleeding, or individuals with continued malabsorption frequently develop recurrent deficiency. Prevention requires identification and definitive treatment of the cause, which may include hormonal or surgical treatment for menorrhagia, Helicobacter pylori eradication in gastritis, treatment of inflammatory bowel disease, or prophylactic supplementation in situations of persistent risk. Periodic laboratory follow-up is recommended in high-risk patients for early detection of recurrence.
Which foods help in prevention and treatment?
Foods rich in heme iron (from animal sources) include red meat, liver, poultry, and fish, being better absorbed than non-heme iron from plant sources. Plant sources include legumes (beans, lentils, chickpeas), dark green vegetables (spinach, kale), fortified cereals, and seeds. Absorption of non-heme iron is significantly increased when consumed with vitamin C (citrus fruits, tomato, bell pepper). Substances that inhibit absorption include phytates (whole grains, legumes), tannins (tea, coffee), calcium (dairy products), and should be avoided at main meals. However, dietary modification alone is rarely sufficient to treat established anemia, with medication supplementation being necessary in most cases.
Are there side effects from iron treatment?
Yes, oral iron supplementation frequently causes gastrointestinal effects including nausea, constipation, abdominal discomfort, and darkened stools (which do not represent bleeding). These effects are dose-dependent and can be minimized by starting with lower doses and increasing gradually, taking iron with food (although this reduces absorption), or switching to slow-release formulations. Approximately 20-30% of patients discontinue treatment due to intolerance. In these cases, alternate-day dosing may be equally effective with better tolerability. Intravenous iron avoids gastrointestinal effects but may cause infusion reactions and, rarely, severe allergic reactions.
Do pregnant women require differentiated treatment?
Yes, pregnant women require special attention due to increased iron requirements during pregnancy and risks associated with anemia for mother and fetus. Iron deficiency anemia in pregnancy is associated with increased risk of preterm delivery, low birth weight, and maternal complications. Prophylactic iron supplementation is recommended for all pregnant women, even without anemia, due to increased requirements. When anemia is present, higher therapeutic doses are necessary. Intravenous treatment may be considered in the second or third trimester in cases of severe anemia or oral intolerance. More frequent laboratory monitoring is recommended during pregnancy to assess response and adjust treatment.
Keywords: iron deficiency anemia, iron deficiency, ICD-11 3A00, microcytic anemia, low ferritin, anemia treatment, medical coding, anemia diagnosis
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - Iron deficiency anemia
- 🔬 PubMed Research on Iron deficiency anemia
- 🌍 WHO Health Topics
- 📊 Clinical Evidence: Iron deficiency anemia
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-03